Glioma-infiltrating Tregs express particularly high levels of CCR4 compared to other tumor-infiltrating lymphocytes (73), and several in vitro migration studies have demonstrated the ability of glioma-derived CCL22 to induce Treg chemotaxis (71–73). This evidence concerns the gene CCR4 and neoplasm.